About Us
Our Promise
Focus Areas
AI
Bio + Healthcare
Consumer
Cloud Infrastructure
Cybersecurity
Fintech
SaaS
Supply Chain + Automation
Team
Portfolio
Perspective
Search for:
Tech-enabled bio
Our Investment in Vilya: AI-Enabled Development of a New Class of Medicines
→
Opportunities and Challenges of Applying Generative AI to Designing New Drugs
→
Video: Engineering New Drugs With Generative AI at Genesis Therapeutics
→
Video: Early Cancer Detection With Delfi
→
Video: Reengineering Drug Discovery With Recursion
→